During the past decade, Centre de Recherche Musculo-Squelettique conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 18 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 14 clinical trials were completed. i.e. 280% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Recherche Musculo-Squelettique" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "CSL Behring" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche Musculo-Squelettique" #1 collaborator was "ArthroLab Inc." with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Recherche Musculo-Squelettique" are "Rheumatoid Arthritis" (9 trials), "Arthritis, Rheumatoid" (4 trials), "Arthritis, Psoriatic" (3 trials), "Osteoarthritis" (3 trials) and "Ankylosing Spondylitis" (2 trials). Many other conditions were trialed in "Centre de Recherche Musculo-Squelettique" in a lesser frequency.

Most popular intervention types in "Centre de Recherche Musculo-Squelettique" are "Drug" (23 trials), "Biological" (7 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Methotrexate" (4 trials), "Adalimumab" (3 trials), "Abatacept" (2 trials) and "BMS-945429" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Recherche Musculo-Squelettique" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Centre de Recherche Musculo-Squelettique". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Centre de Recherche Musculo-Squelettique, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Recherche Musculo-Squelettique, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".